Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,961,188
+$20,534 QoQ
Shares Held
44,418
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#218
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Steward Partners Investment Advisory, LLC holds $502,917,200 across 18 Drug Manufacturers - General names. NVS ranks #9 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
116,568 | $139,815,167 | |
| 2 | ABBV |
AbbVie Inc.
|
475,389 | $119,626,887 | |
| 3 | JNJ |
Johnson & Johnson
|
461,457 | $117,196,234 | |
| 4 | MRK |
Merck & Co., Inc.
|
318,918 | $40,980,963 | |
| 5 | AMGN |
Amgen Inc
|
79,642 | $28,839,961 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
277,131 | $15,968,288 | |
| 7 | PFE |
Pfizer Inc
|
520,623 | $12,536,601 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
66,698 | $8,426,625 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,961,188 | 44,418 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,940,654 | 45,438 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,480,964 | 54,261 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,729,265 | 52,474 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,711,550 | 47,199 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,858,855 | 43,585 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,313,168 | 44,324 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,427,218 | 47,185 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,862,560 | 45,675 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,313,577 | 44,594 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,771,633 | 37,354 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,583,944 | 35,185 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,427,307 | 33,964 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,515,648 | 27,344 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,350,192 | 25,906 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,989,789 | 26,178 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,288,565 | 27,074 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,383,114 | 27,158 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,962,914 | 22,441 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,944,646 | 23,779 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,004,067 | 43,885 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,535,935 | 29,667 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,233,552 | 23,653 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,085,213 | 23,979 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,888,814 | 21,626 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,623,605 | 19,692 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||